hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis

被引:29
|
作者
Han, Fengjiao [1 ]
Zhong, Chaoqin [1 ,2 ]
Li, Wei [1 ]
Wang, Ruiqing [1 ]
Zhang, Chen [1 ]
Yang, Xinyu [1 ]
Ji, Chunyan [1 ]
Ma, Daoxin [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China
[2] Yantai Mt Hosp, Dept Hematol, Yantai 264000, Peoples R China
基金
中国国家自然科学基金;
关键词
AML; biomarker; circRNAs; CREBRF; hsa_circ_0001947; hsa-miR-329-5p; therapy; CIRCULAR RNAS; GASTRIC-CANCER; CELL-GROWTH; IDENTIFICATION; CREBRF; SPONGE; GENE; ACTS;
D O I
10.2217/epi-2019-0352
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML. Materials & methods: We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship. Results:hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis. Conclusion:hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.
引用
下载
收藏
页码:935 / 953
页数:19
相关论文
共 50 条
  • [1] Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p/HDGF axis
    Hu, Qingzhu
    Gu, Yueli
    Chen, Shuxia
    Tian, Ying
    Yang, Shuo
    AGING-US, 2021, 13 (01): : 1120 - 1131
  • [2] Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis
    Tang, Xi
    Wen, Xiaomin
    Li, Zhouyu
    Wen, Danxia
    Lin, Ling
    Liu, Jinquan
    Li, Mingyi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (07) : 4973 - 4984
  • [3] Hsa_circ_0002483 regulates miR-758-3p/MYC axis to promote acute myeloid leukemia progression
    Xiao, Yi
    Ming, Xi
    Wu, Jiaying
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (02) : 243 - 253
  • [4] Hsa_circ_0003356 suppresses gastric cancer progression via miR-556-5p/ FKBP5 axis
    Lu, Chuanhui
    Wu, Jing
    Li, Xiaoguang
    Huang, Wei
    Fang, Yongmu
    Huang, Ying
    TOXICOLOGY IN VITRO, 2024, 97
  • [5] Hsa_circ_0004776 regulates the retina neovascularization in progression of diabetic retinopathy via hsa-miR-382-5p/BDNF axis
    Ye, Lu
    Chen, Yixiu
    Gu, Wendong
    Shao, Jun
    Xin, Yu
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2024,
  • [6] Hsa_circ_0044907 promotes acute myeloid leukemia progression through upregulating oncogene KIT via sequestering miR-186-5p
    Liu, Ling
    Qiang, Xing
    HEMATOLOGY, 2022, 27 (01) : 960 - 970
  • [7] Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis
    Zhang, Shilong
    Zhang, Xiangsheng
    Chen, Guoxiao
    Zheng, Xiaokang
    Zhu, Xiaobo
    Shan, Lei
    EXPERIMENTAL CELL RESEARCH, 2020, 395 (02)
  • [8] Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development
    Bao, Yuyan
    Yu, Yanjie
    Hong, Bing
    Lin, Zhenjian
    Qi, Guoli
    Zhou, Jie
    Liu, Kaiping
    Zhang, Xiaomin
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (11) : 1508 - 1518
  • [9] hsa_circ_0000519 promotes the progression of lung adenocarcinoma through the hsa-miR-1296-5p/DARS axis
    Tu, Guangxu
    Peng, Weilin
    Peng, Xiong
    Zhao, Zhenyu
    Shi, Shuai
    Cai, Qidong
    He, Boxue
    Yin, Wei
    Peng, Shaoliang
    Wang, Li
    Yu, Fenglei
    Wang, Xiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3342 - +
  • [10] Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer via Sponging hsa-miR-20a-5p/93-5p/106b-5p
    Liao, Wenyan
    He, Jun
    Disoma, Cyrollah
    Hu, Yi
    Li, Junhua
    Chen, Guodong
    Sheng, Ying
    Cai, Xinyu
    Li, Chuanfu
    Cheng, Kai
    Yang, Chunfen
    Qin, Yongxi
    Han, Dong
    Wen, Wu
    Ding, Chengming
    Li, Mujun
    FRONTIERS IN ONCOLOGY, 2021, 10